STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Enovis Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Davenport & Co LLC reported beneficial ownership of 2,756,270 shares of Enovis common stock, representing 4.83% of the class. The filer discloses sole voting power over 2,730,225 shares and sole dispositive power over 2,756,145 shares. The statement is filed on Schedule 13G as an investment adviser and indicates the holding is 5% or less of the class.

This filing also contains a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A sub-5% institutional stake was reported, showing a modest position without control intent.

The Schedule 13G/A shows Davenport & Co LLC beneficially owns 2,756,270 shares (4.83%) of Enovis with substantial sole voting and dispositive power noted. Because the filing is a 13G and Item 10 includes a certification of ordinary-course holdings, this indicates a passive investment rather than an active control effort. For most investors, a 4.83% stake is notable for disclosure but not typically material to governance or control.

TL;DR: Disclosure signals transparency; ownership below 5% limits immediate governance impact.

The filing explicitly classifies the filer as an investment adviser and records sole voting power for 2,730,225 shares. The certifying language states the position is held in the ordinary course and not to influence control, which aligns with a passive reporting posture. Given the 5% threshold remains unmet, the filing does not, by itself, trigger heightened governance concerns or control-related filings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



DAVENPORT & Co LLC
Signature:Alison Crowder
Name/Title:CCO - Investment Advisory
Date:08/12/2025

FAQ

What stake does Davenport & Co LLC report in Enovis (ENOV)?

Davenport & Co LLC reports beneficial ownership of 2,756,270 shares, equal to 4.83% of Enovis common stock.

How many shares does Davenport report having sole voting power over?

The filer reports sole voting power for 2,730,225 shares.

Does the filing indicate Davenport intends to influence control of Enovis (ENOV)?

No. The filing includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

Under what schedule and classification was this ownership reported?

The position was reported on Schedule 13G/A and the reporting person is classified as an investment adviser (IA).

Is this ownership considered a 5% or greater stake?

No. Item 5 indicates ownership is of 5 percent or less of the class.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.53B
56.28M
1.57%
121.34%
12.07%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON